118 related articles for article (PubMed ID: 6619034)
1. Clinical experience with azlocillin.
Sanders WE
J Antimicrob Chemother; 1983 May; 11 Suppl B():69-75. PubMed ID: 6619034
[TBL] [Abstract][Full Text] [Related]
2. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
3. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
Weingärtner L; Sitka U; Patsch R; Thiemann HH
Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
Dzierzanowska D; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
[TBL] [Abstract][Full Text] [Related]
5. Azlocillin: a new broad spectrum penicillin.
Sanders CC
J Antimicrob Chemother; 1983 May; 11 Suppl B():21-31. PubMed ID: 6619029
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
[TBL] [Abstract][Full Text] [Related]
7. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
Drusano GL; Schimpff SC; Hewitt WL
Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
Verbist L
Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
Machka K; Dickert H; Braveny I
Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
[TBL] [Abstract][Full Text] [Related]
10. The use of azlocillin to treat serious infections.
Neu HC; Francke EL; Ortiz-Neu C; Prince AS
J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
Coppens L; Klastersky J
Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
del Rosal PL
J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
[TBL] [Abstract][Full Text] [Related]
13. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.
Wise R; Gillett AP; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Apr; 13(4):559-65. PubMed ID: 96726
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
15. Treatment of serious Pseudomonas infections with azlocillin.
Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
Vestin L; Burman LA; Holm S; Sellers J
Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
Cerikcioğlu N; Ustaçelebi S; Günalp A
Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
[TBL] [Abstract][Full Text] [Related]
19. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Traub WH
Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
[TBL] [Abstract][Full Text] [Related]
20. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
